Inspire Medical Systems, Inc. is a medical technology company focused on the development and commercialization of an innovative solution for patients with obstructive sleep apnea (OSA).
Inspire has developed the first and only FDA-approved neurostimulation device that provides a safe and effective treatment for moderate-to-severe OSA. The Inspire system is a novel closed-loop solution that uses a proprietary algorithm to continuously monitor a patient’s breathing patterns and delivers mild stimulation to the hypoglossal nerve to maintain an open airway during sleep. Inspire therapy is designed to reduce OSA severity and improve quality of life for patients living with this challenging condition.
Inspire was formed in 2007 when the technology and a significant intellectual property portfolio were spun out of Medtronic (NYSE: MDT).